Per-Encounter Medical Market Size is valued at USD 121.82 Bn in 2023 and is predicted to reach USD 377.93 Bn by the year 2031 at a 15.38% CAGR during the forecast period for 2024-2031. Per-encounter medical describes a billing model in which a healthcare practitioner charges a set amount for each patient encounter. This means the patient will always be charged the same amount for each appointment, no matter how long or complicated. ...
Report ID: 2253 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Botulinum Toxin in Urology Market Size is valued at USD 948.56 Mn in 2023 and is predicted to reach USD 1,504.89 Mn by the year 2031 at a 6.05% CAGR during the forecast period for 2024-2031. Botulinum toxin, commonly known as Botox, has found applications in the field of urology for the treatment of various medical conditions, particularly those related to the lower urinary tract. A range of significant factors drives the growth of ...
Report ID: 2255 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Medical Nitrous Oxide Market Size is valued at USD 1.76 Bn in 2023 and is predicted to reach USD 3.03 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2024-2031. Medical nitrous oxide, often known as N2O, is a colourless and odourless gas that has been utilized in medical settings for over a century. It is popularly referred to as "laughing gas" because of the euphoric effects it produces when inhaled in small doses. Nitrous ...
Report ID: 2329 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 180
The iPSC Characterization Kit Market Size is predicted to grow at an 15.54 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The advent of the iPSC characterization kit market arose for technological innovation, regulatory support, and collaborative partnerships that propel stem cell research forward. The increasing applications in research and therapy are expected to drive this marke...
Report ID: 1418 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 185
The FMS-like Tyrosine Kinase 3 Inhibitors Market Size is valued at 495.07 Million in 2023 and is predicted to reach 1455.43 Million by the year 2031 at a 14.74 % CAGR during the forecast period for 2024-2031. The effects of inhibitors have been documented in acute myeloid leukemia patients with FMS-like tyrosine kinase 3 inhibitors3 mutations, as part of the Non-Insured Health Benefits (NIHB) program. FMS-like tyrosine kinase 3...
Report ID: 1389 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 185
The Global Multiple Cancer Monoclonal Antibodies Market Size is valued at 67.21 billion in 2023 and is predicted to reach 154.24 billion by the year 2031 at a 11.19% CAGR during the forecast period for 2024-2031. Cancer monoclonal antibodies are specific antibodies with identical immune cells that are clones of a single parent cell directed to specific cellular targets. Thus, monoclonal antibodies are preciously customizable due to their ...
Report ID: 1112 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 190
The Bioelectric Medicine Market Size is valued at 24.08 Billion in 2023 and is predicted to reach 43.03 Billion by the year 2031 at a 7.72 % CAGR during the forecast period for 2024-2031. Bioelectric medicine is a branch of medicine that combines neurobiology, engineering science, and molecular medicine to create nerve stimulation technologies for monitoring biological parameters during treatment. The application of electrical impuls...
Report ID: 1379 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 160
Small Molecule Immunomodulators Market Size is valued at USD 170.74 Bn in 2023 and is predicted to reach USD 270.77 Bn by the year 2031 at a 6.07% CAGR during the forecast period for 2024-2031. Small molecule immunomodulators are compounds with low molecular weights that influence the immune system. They can be immunosuppressants (e.g., corticosteroids, JAK inhibitors) or immunostimulants (e.g., TLR agonists). Examples include methotrexate for...
Report ID: 2307 |
Delivery: Immediate |
Published: January 2024 |
No. of Pages: 180
Pharmaceuticals